Evidence-Based Toxicology - The Toolbox of Validation for the 21 st Century?

Altex

Volumn 27, Issue 4, 2010, Pages 253-263

  Hartung, Thomas ^a,b  

^a JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^b UNIVERSITY OF KONSTANZ   (Germany)

Author keywords

Alternative methods; Cell culture; Evidence based medicine; Genomics; Quality assurance

Indexed keywords

ESTROGEN; TRICHLOROETHYLENE;

ANIMAL TESTING ALTERNATIVE; CANCER RISK; CELL PROLIFERATION; CLINICAL EFFECTIVENESS; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; DOSE RESPONSE; EMBRYONIC STEM CELL; EVIDENCE BASED MEDICINE; EVIDENCE BASED TOXICOLOGY; EYE IRRITATION; FEASIBILITY STUDY; GENE EXPRESSION PROFILING; HUMAN; IN VITRO STUDY; IN VIVO STUDY; MEDICAL RESEARCH; METABOLOMICS; NUCLEAR MAGNETIC RESONANCE; OUTCOME ASSESSMENT; PRACTICE GUIDELINE; PREDICTIVE VALUE; PROSPECTIVE STUDY; QUALITY CONTROL; REPORTER GENE; REPRODUCIBILITY; RETROSPECTIVE STUDY; REVIEW; RISK ASSESSMENT; SENSITIVITY AND SPECIFICITY; TOXICITY TESTING; VALIDATION STUDY; ANIMAL; ARTICLE; CULTURE TECHNIQUE; ECONOMICS; GENOMICS; METHODOLOGY; STANDARD; TOXICOLOGY;

ANIMAL TESTING ALTERNATIVES; ANIMALS; CELL CULTURE TECHNIQUES; GENOMICS; HUMANS; REPRODUCIBILITY OF RESULTS; TOXICOLOGY;

EID: 79952311389     PISSN: 09467785     EISSN: None     Source Type: Journal    
DOI: 10.14573/altex.2010.4.253     Document Type: Review

References (92)

1. Adler, S., Pellizzer, C., Hareng, L. et al. (2008). First steps in establishing a developmental toxicity test method based on human embryonic stem cells. Toxicol. In Vitro 22, 200-211. (Pubitemid 350267101)
2. Ahr, H.-J., Alepee, N., Breier, S. et al. (2008). Barriers to validation. A report by European Partnership for Alternative Approaches to animal testing (EPAA) working group 5. ATLA 36, 459-464.
3. st century: bringing the vision to life. Toxicol. Sci. 107, 324-330.
4. Balls, M., Amcoff, P., Bremer, S. et al. (2006). The principles of weight of evidence validation of test methods and testing strategies. The report and recommendations of ECVAM workshop 58. ATLA 34, 603-620. (Pubitemid 46238600)
5. Balls, M., Blaauboer, B., Brusick, D. et al. (1990). Report and recommendations of the CAAT/ERGATT workshop on the validation of toxicity test procedures. ATLA 18, 313-337.
6. Barton, H. A., Chiu, W. A., Woodrow Setzer, R. et al. (2007). Characterizing uncertainty and variability in physiologically based pharmacokinetic models: state of the science and needs for research and implementation. Toxicol. Sci. 99, 395-402. (Pubitemid 351753057)
7. st century: using the new toxicity testing paradigm to create a taxonomy of adverse effects. Toxicol. Sci. 114, 20-24.
8. Bosl, W. J. (2007). Systems biology by the rules: hybrid intelligent systems for pathway modeling and discovery. BMC Syst. Biol. 1, 13.
9. nd edition). Chichester, UK: Wiley Blackwell.
10. Bottini, A. A. and Hartung, T. (2009). Food for thought... on the economics of animal testing. ALTEX 26, 3-16.
11. Bottini, A. A., Alepee, N., De Silva, O. et al. (2008). Optimization of the post-validation process. The report and recommendations of ECVAM workshop 67. ATLA 36, 353-366.
12. Bouvier d'Yvoire, M., Prieto, P., Blaauboer, B. J. (2007). Physiologically-based kinetic modelling (PBK modelling): Meeting the 3Rs Agenda. The report and recommendations of ECVAM workshop 63. ATLA 35, 661-671.
13. Brazma, A., Hingamp, P., Quackenbush, J. (2001). Minimum information about a microarray experiment (MIAME) - toward standards for microarray data. Nat. Genet. 29, 365-371. (Pubitemid 34326681)
14. Bremer, S. and Hartung, T. (2004). The use of embryonic stem cells for regulatory developmental toxicity testing in vitro - the current status of test development. Curr. Pharm. Des. 10, 2733-2747. (Pubitemid 39137172)
15. nd edition). Chichester, UK: Wiley Blackwell.
16. st century. Toxicol. Sci. 112, 17-22.
17. Chiu, W. A., Barton, H. A., DeWoskin, R. S. et al. (2007). Evaluation of physiologically based pharmacokinetic models for use in risk assessment. J. Appl. Toxicol. 27, 218-237. (Pubitemid 46663416)
18. Cho, C. R., Labow, M., Reinhardt, M. et al. (2006). The application of systems biology to drug discovery. Curr. Opin. Chem. Biol. 10, 294-302. (Pubitemid 44080655)
19. Clewell, R. A. and Clewell, H. J. 3rd (2008). Development and specification of physiologically based pharmacokinetic models for use in risk assessment. Regul. Toxicol. Pharmacol. 50, 129-143. (Pubitemid 50013231)
20. Coecke, S., Goldberg, A. M., Allen, S. et al. (2007). Incorporating in vitro alternative methods for developmental neurotoxicity into international hazard and risk assessment strategies. Environ. Health Persp. 115, 924-931. (Pubitemid 46902248)
21. Coecke, S., Balls, M., Bowe, G. et al. (2005). Guidance on good cell culture practice. a report of the second ECVAM task force on good cell culture practice. ATLA 33, 261-287. (Pubitemid 40964979)
22. Collins, F. S., Gray, G. M. and Bucher, J. R. (2008). Toxicology: Transforming environmental health protection. Science 319, 906-907. (Pubitemid 351263750)
23. Coons, S. J. (2009). The FDA's critical path initiative: a brief introduction. Clin. Ther. 31, 2572-2573.
24. Corvi, R., Albertini, S., Hartung, T. et al. (2008). ECVAM retrospective validation of in vitro micronucleus test (MNT). Mutagenesis 23, 271-283. (Pubitemid 351918959)
25. Corvi, R., Ahr, H. J., Albertini, S. et al. (2006). Meeting report: Validation of toxicogenomics-based test systems: ECVAM-IC-CVAM/NICEATM considerations for regulatory use. Environ. Health Perspect. 114, 420-429. (Pubitemid 43338268)
26. Daneshian, M., Leist, M. and Hartung, T. (2010). The Center for Alternatives to Animal Testing - Europe (CAAT-EU): a transatlantic bridge for the paradigm shift in toxicology. ALTEX 27, 63-69.
27. Davila, J. C., Cezar, G. G., Thiede, M. et al. (2004). Use and application of stem cells in toxicology. Toxicol. Sci. 79, 214-223. (Pubitemid 38786878)
28. European Chemicals Agency (2008). Guidance on information requirements and chemical safety assessment (2178). Helsinki, Finland: European Chemicals Agency. Available at: http://guidance.echa.europa.eu/docs/guidance-document/ information-requirements-en.htm (accessed 17 April 2009).
29. FDA (2004). FDA: Challenge and opportunity on the critical path to new medical products. http://www.fda.gov/ScienceResearch/SpecialTopics/ CriticalPathInitiative/CriticalPathOpportunitiesReports/ucm077262.htm (accessed 20 April 2010).
30. Fischer, H. P. (2005). Towards quantitative biology: integration of biological information to elucidate disease pathways and to guide drug discovery. Biotechnol. Annu. Rev 11, 1-68.
31. st century: a vision and a strategy. Reprod. Toxicol. 25, 136-138.
32. Goldberg, A. and Hartung, T. (2008). The emerging new toxicology - an opportunity for contract research. Eur. Pharmaceut. Contractor, 42-46.
33. Grandjean, P. and Landrigan, P. J. (2006). Developmental neurotoxicity of industrial chemicals. Lancet 368, 2167-2178. (Pubitemid 44894541)
34. Griesinger, C., Hoffmann, S., Kinsner-Ovaskainen, A. (2009). Proceedings of the first international forum towards evidence-based toxicology. Conference Centre Spazio Villa Erba, Como, Italy. 15-18 October 2007. Hum. Exp. Toxicol., Spec. Issue: Evidence-based Toxicology (EBT) 28, 81-163.
35. Griffin, J. L., Nicholls, A. W., Daykin, C. A. et al. (2007). Standard reporting requirements for biological samples in metabolomics experiments: mammalian/in vivo experiments. Metabolomics 3, 179-188. (Pubitemid 47470686)
36. Guzelian, P. S., Victoroff, M. S., Halmes, N. C. et al. (2005). Evidence-based toxicology: a comprehensive framework for causation. Hum. Exp. Toxicol. 24, 161-201. (Pubitemid 40778683)
37. ndedition). Chichester, UK: Wiley Blackwell.
38. st century. J. Toxicol. Env. Health 13, 277-290.
39. Hartung, T. (2010b). Food for thought ... on alternative methods for chemical safety testing. ALTEX 27, 3-14.
40. Hartung, T. (2010c). Food for thought ... on alternative methods for nanoparticle safety testing. ALTEX 27, 87-95.
41. Hartung, T., Bruner, L., Curren, R. et al. (2010). First alternative method validated by a retrospective weight-of-evidence approach to replace the Draize eye test for the identification of non-irritant substances for a defined applicability domain. ALTEX 27, 43-51.
42. Hartung, T. and Hoffmann, S. (2009). Food for thought on ... in silico methods in toxicology. ALTEX 26,155-166.
43. Hartung, T. (2009a). Toxicology for the twenty-first century. Nature 460, 208-212.
44. Hartung, T. (2009b). Food for thought... on evidence-based toxicology. ALTEX 26, 75-82.
45. st century: Mapping the road ahead. Toxicol. Sci. 109, 18-23.
46. Hartung, T. (2008a). Towards a new toxicology - evolution or revolution? ATLA 36, 635-639.
47. Hartung, T. (2008b). Food for thought ... on animal tests. ALTEX 25, 3-9.
48. Hartung, T. and Leist, M. (2008). Food for thought ... on the evolution of toxicology and phasing out of animal testing. ALTEX 25, 91-96.
49. Hartung, T. (2007a). Food for thought ... on validation. ALTEX 24, 67-72.
50. Hartung, T. (2007b). Food for thought ... on cell culture. ALTEX 24, 143-147.
51. Hartung, T., Bremer, S., Casati, S. et al. (2004). A modular approach to the ECVAM principles on test validity. ATLA 32, 467-472. (Pubitemid 40128842)
52. nd edition). Chichester, UK: Wiley Blackwell.
53. Hoffmann, S., Edler, L., Gardner, I. et al. (2008). Points of reference in validation - the report and recommendations of ECVAM Workshop. ATLA 36, 343-352.
54. Hoffmann, S. and Hartung, T. (2006). Towards an evidence-based toxicology. Hum. Exp. Toxicol. 25, 497-513.
55. Hoffmann, S. and Hartung, T. (2005). Diagnosis: Toxic! - Trying to apply approaches of clinical diagnostics and prevalence in toxicology considerations. Toxicol. Sci. 85, 422-428. (Pubitemid 40614273)
56. Hogberg, H. T., Kinsner-Ovaskainen, A., Coecke, S. et al. (2010). mRNA expression is a relevant tool to identify developmental neurotoxicants using an in vitro approach. Toxicol. Sci. 113, 95-115.
57. Hogberg, H. T., Kinsner-Ovaskainen, A., Hartung, T. et al. (2009). Gene expression as a sensitive endpoint to evaluate cell differentiation and maturation of the developing central nervous system in primary cultures of rat cerebellar granule cells (CGCs) exposed to pesticides. Toxicol. Appl. Pharmacol. 235, 268-286.
58. Horvath, A. R. and Pewsner, D. (2004). Systematic reviews in laboratory medicine: principles, processes and practical considerations. Clin. Chim. Acta 342, 23-39. (Pubitemid 38352912)
59. Judson, R. S., Houck, K. A., Kavlock, R. J. (2010). In vitro screening of environmental chemicals for targeted testing prioritization: the ToxCast project. Environ. Health Perspect. 118, 485-492.
60. Judson, R., Richard, A., Dix, D. J. et al. (2009). The toxicity data landscape for environmental chemicals. Environ. Health Perspect. 117, 685-695.
61. Kavlock, R. J. (2009). The future of toxicity testing - the NRC vision and the EPA's ToxCast program national center for computational toxicology. Neurotoxicol. Teratol. 31, 237.
62. st century: Implications for Human Health Risk Assessment. Risk Analysis 29, 485-487.
63. Kinsner-Ovaskainen, A., Akkan, Z., Casati, S. et al. (2009). Overcoming barriers to validation of non-animal partial replacement methods/integrated testing strategies: The report of an EPAA-ECVAM workshop. ATLA 37, 1-8.
64. ndedition, pp.302). Chichester, UK: Wiley Blackwell.
65. Kroes, R., Kleiner, J. and Renwick, A. (2005). The threshold of toxicological concern concept in risk assessment. Toxicol. Sci. 86, 226-230. (Pubitemid 41418634)
66. Kwoh, C. K. and Ng, P. Y. (2007). Network analysis approach for biology. Cell Mol. Life Sci. 64, 1739-1751.
67. Leist, M., Bremer, S., Brundin, P. et al. (2008a). The biological and ethical basis of the use of human embryonic stem cells for in vitro test systems or cell therapy. ALTEX 25, 163-190.
68. Leist, M., Hartung, T. and Nicotera, P. (2008b). The dawning of a new age of toxicology. ALTEX 25, 103-114.
69. Mayer, D. (2004). Essential evidence-based medicine (1-381). Cambridge: Cambridge University Press.
70. Martinez di Montemuros, F. and Parise, P. (2008). New technologies from siRNA world. Minerva Biotec. 20, 3-11.
71. Matin, M. M., Walsh, J. R., Gokhale, P. J. et al. (2004). Specific knockdown of Oct4 and beta2-microglobulin expression by RNA interference in human embryonic stem cells and embryonic carcinoma cells. Stem Cells 22, 659-668. (Pubitemid 39166924)
72. st edition). Florida, USA: CRC-Press, Boca Raton.
73. st century: a vision and a strategy. The National Academies Press, 196.
74. NRC (2000). NRC: Scientific frontiers in developmental toxicology and risk assessment. National Academy Press, Washington DC.
75. OECD (2005). Guidance document on the validation and International acceptance of new or updated test methods for hazard assessment. ENV/JM/MONO(2005)14. OECD Series on Testing and Assessment 34, 96pp. Paris, France: Organisation for Economic Co-operation and Development. Available at: http://www.oecd.org/officialdocuments/displaydocumentpdf?cote=env/jm/mono(2005) 14&doclanguage=en
76. Pellizzer, C., Bremer, S. and Hartung, T. (2005). Developmental toxicity testing from animal towards embryonic stem cells. ALTEX 22, 47-57. (Pubitemid 40974877)
77. Robertson, D. G. (2005). Metabonomics in toxicology: a review. Toxicol. Sci. 85, 809-822.
78. Rudén, C. (2001a). Interpretations of primary carcinogenicity data in 29 trichloroethylene risk assessments. Toxicol., 169-225.
79. Rudén, C. (2001b). The use and evaluation of primary data in 29 trichloroethylene carcinogen risk assessments. Regulat. Toxicol. Pharmacol. 34, 3-16.
80. Sansone, S. A., Schober, D., Atherton, H. J. et al. (2007). Metabolomics standards initiative: ontology working group work in progress. Metabolomics 3, 249-256. (Pubitemid 47470694)
81. Schneider, K., Schwarz, M., Burkholder, I. et al. (2009). "ToxR-Tool", a new tool to assess the reliability of toxicological data. Toxicol. Lett. 189, 138-144.
82. Seidle, T. and Stephens, M. L. (2009). Bringing toxicology into the 21st century: A global call to action. Toxicol. In Vitro 23, 1576-1579.
83. Skrabanek, P. and McCormick, J. (1989). Follies and fallacies in medicine. Glasgow: Tarragon Press.
84. Stummann, T. C. and Bremer, S. (2008). The possible impact of human embryonic stem cells on safety pharmacological and toxicological assessments in drug discovery and drug development. Curr. Stem Cell Res. Ther. 3, 117-130. (Pubitemid 352024858)
85. Vallier, L., Rugg-Gunn, P. J., Bouhon, I. A. et al. (2004). Enhancing and diminishing gene function in human embryonic stem cells. Stem Cells 22, 2-11. (Pubitemid 38018776)
86. van der Werf, M. J., Takors, R., Smedsgaard, J. et al. (2007). Standard reporting requirements for biological samples in metabolomics experiments: microbial and in vitro biology experiments. Metabolomics 3, 189-194. (Pubitemid 47470687)
87. nd edition). Dordrecht, The Netherlands: Springer.
88. van Vliet, E., Morath, S., Eskes, C. et al. (2008). A novel in vitro metabolomics approach for neurotoxicity testing, proof of principle for methyl mercury chloride and caffeine. Neurotoxicol. 29, 1-12.
89. Vinken, M., Doktorova, T., Ellinger-Ziegelbauer, H. et al. (2008). The carcinoGENOMICS project: critical selection of model compounds for the development of omics-based in vitro carcinogenicity screening assays. Mutat. Res. 659, 202-210.
90. Wandall, B., Hansson, S. O. and Rudén, C. (2007). Bias in toxicology. Arch. Toxicol. 81, 605-617. (Pubitemid 47228770)
91. Yang, R. S., Thomas, R. S., Gustafson, D. L. et al. (1998). Approaches to developing alternative and predictive toxicology based on PBPK/PD and QSAR modeling. Environ. Health Perspect. 106, Suppl. 6, 1385-1393. (Pubitemid 29073883)
92. Zaehres, H., Lensch, M. W., Daheron, L. et al. (2005). High-efficiency RNA interference in human embryonic stem cells. Stem Cells 23, 299-305. (Pubitemid 40404448)